Lariago DS (Chloroquine)
What is Lariago DS (Chloroquine) used for?
Lariago DS (Chloroquine) is an oral medication prescribed to treat or prevent malaria. This condition is normally contracted from mosquito bites in certain areas of the world. The medication interferes with the growth of the parasites allowing the immune system to destroy them. It may also be used for the treatment of rheumatoid arthritis or systemic lupus in some cases. Your physician may prescribe it for other unlisted purposes, as well.
How should I use Lariago DS (Chloroquine)?
Strictly follow your physician's instructions while using Lariago DS (Chloroquine) to get the best results from treatment. When used to prevent malaria during travel, one tablet is normally taken weekly for one to two weeks before, during, and the four to eight weeks following the trip to make sure any parasites are destroyed. Your dosage and frequency of administration will differ depending on if you are already infected, the condition being treated, and the severity of your symptoms. Do not stop taking the medication prior to being told to do so as the infection may not be destroyed and can return stronger or more resistant to treatment. Take the doses with a large glass of water and may be taken with or without food, but a meal or snack is recommended if you get an upset stomach. Never split, crush, or chew the tablets before use as this may destroy or alter the effects of their contents. Ask your pharmacist or physician any questions you have about the medication to ensure the correct administration.
What are the side effects of Lariago DS (Chloroquine)?
Some patients using Lariago DS (Chloroquine) may experience side effects such as:
More serious side effects that may require emergency medical attention include severe muscle weakness, hearing loss, loss of coordination, vision problems, severe skin reactions, seizures, darkened urine, discolored stools, or jaundice. Immediately inform your physician of any symptoms that worry you or are intense to make sure the correct changes are made to your regimen to prevent more problems from occurring.
Lariago DS (Chloroquine) should not be administered to patients with epilepsy. Also disclose if you have a history of epilepsy, psoriasis, porphyrias, myasthenia gravis, neurological disorders, G6PD deficiency, intestinal disorders, liver disease, or kidney disease as these conditions may require reduced dosages to prevent more problems from occurring.
Strictly follow all instructions provided to you by your physician or pharmacist while using Lariago DS (Chloroquine). Optimum and safe dosage can differ based on the patient and the condition being treated.
As this medication may be unsafe for certain patients, it is essential you always inform your physician if you are pregnant or breastfeeding, as well as if you have any allergies, other illnesses, or ongoing health conditions, and if you are taking any other form of medication, supplements, or herbal products.
Immediately seek emergency medical care if you have an allergic or hypersensitive reaction. Common signs of a reaction include hives, swelling, skin rashes, chest pains, as well as trouble breathing or swallowing.